Chan Phillip P. purchased $105K of CTSO
Chan Phillip P. (Chief Executive Officer) purchased 261,469 shares of Cytosorbents Corp (CTSO) at an average of $0.40 ($0.40–$0.43, $0.10M total) across 2 trades over 2026-06-12 to 2026-06-15.
How this was made
The 30-second read
Why it matters
The newest information is the CEO’s open-market purchase details (shares, price range, total value) and that it was not under a pre-arranged 10b5-1 plan.
Market read
Traders may treat this as a small sentiment input, but it does not replace fundamental catalysts (earnings, trial results, contracts, or financing).
What to watch
The article notes no 10b5-1 plan, but it does not disclose motivations, option exercises, or whether additional insider activity occurred around the same period.
Background
The article is an SEC Form 4 insider transaction disclosure for Cytosorbents Corp (CTSO).
Ticker impact
Cytosorbents CEO Chan Phillip P. bought $104.9K of CTSO shares in two open-market trades (261,469 shares) per Form 4.
Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures or operational news.
The filing is a primary-source insider transaction, but the article provides no new business development—only the size, price range, and that it was not under a pre-arranged 10b5-1 plan.
Market effects
No sector-wide read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
CEO buying can be driven by personal liquidity needs or diversification rather than a forward-looking view; without accompanying operational news, price reaction may be muted.
Key entities
- issuerCytosorbents Corp
Subject of the Form 4 insider transaction disclosure.
- insiderChan Phillip P.
CEO and officer/director who purchased CTSO shares.
